๐ฐ Acelyrin News
Page 3 - Acelyrin News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Acelyrin. Real-time updates on events, politics, business and more.
December 17, 2023
Wells Fargo & Company initiated coverage on shares of Acelyrin (NASDAQ:SLRN – Free Report) in a research report sent to investors on Wednesday morning, MarketBeat.com reports. The brokerage issued an equal weight rating and a $11.00 price objective on the stock. A number of other analysts also recently commented on the stock. Citigroup assumed coverage […]
December 16, 2023
NEW YORK, Dec. 16, 2023 (GLOBE NEWSWIRE) -- WHY:ย Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ACELYRIN, INC....
December 12, 2023
Citigroup assumed coverage on shares of Acelyrin (NASDAQ:SLRN – Free Report) in a research report report published on Friday morning, MarketBeat Ratings reports. The firm issued a neutral rating and a $8.00 price objective on the stock. SLRN has been the topic of several other reports. Morgan Stanley reduced their price objective on Acelyrin from […]
December 8, 2023
Shares of Acelyrin, Inc. (NASDAQ:SLRN – Get Free Report) gapped down before the market opened on Friday . The stock had previously closed at $7.16, but opened at $6.96. Acelyrin shares last traded at $7.06, with a volume of 38,851 shares. Analyst Upgrades and Downgrades SLRN has been the subject of a number of research […]
December 3, 2023
Ghisallo Capital Management LLC purchased a new position in Acelyrin, Inc. (NASDAQ:SLRN – Free Report) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 70,000 shares of the company’s stock, valued at approximately $1,463,000. Ghisallo Capital Management LLC owned 0.07% of Acelyrin at the end […]
December 3, 2023
Driehaus Capital Management LLC acquired a new position in shares of Acelyrin, Inc. (NASDAQ:SLRN – Free Report) during the second quarter, HoldingsChannel.com reports. The institutional investor acquired 1,758,797 shares of the company’s stock, valued at approximately $36,759,000. A number of other hedge funds and other institutional investors have also bought and sold shares of the […]
December 3, 2023
Driehaus Capital Management LLC bought a new stake in Acelyrin, Inc. (NASDAQ:SLRN – Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 1,758,797 shares of the company’s stock, valued at approximately $36,759,000. Driehaus Capital Management LLC owned about 1.81% of […]
December 3, 2023
CHI Advisors LLC bought a new position in shares of Acelyrin, Inc. (NASDAQ:SLRN – Free Report) during the 2nd quarter, Holdings Channel.com reports. The firm bought 2,663,806 shares of the company’s stock, valued at approximately $55,674,000. Acelyrin makes up 16.8% of CHI Advisors LLC’s holdings, making the stock its 2nd biggest holding. Other hedge funds […]
December 3, 2023
CHI Advisors LLC acquired a new stake in Acelyrin, Inc. (NASDAQ:SLRN – Free Report) in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 2,663,806 shares of the company’s stock, valued at approximately $55,674,000. Acelyrin comprises approximately 16.8% of CHI Advisors LLC’s […]
December 2, 2023
HC Wainwright restated their buy rating on shares of Acelyrin (NASDAQ:SLRN – Free Report) in a research note released on Tuesday, Benzinga reports. The firm currently has a $30.00 target price on the stock. Separately, Morgan Stanley lowered Acelyrin from an overweight rating to an equal weight rating and dropped their target price for the […]